Transpire Bio’s ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA

B SUNRISE, Fla., May 11, 2026 /PRNewswire/ — Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company developing inhaled therapeutics for pulmonary and systemic diseases, today…
posteditor
posteditor
Articles: 21727

Other News